Colestilan

考来替兰

Report date: 2026/03/20 20:03:07
NME

Base Information

Drug NameColestilan
Drug Alias NameColestimideColestilanumColestilan chlorideBindRenCholebine +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBile acid binding protein modulators
TargetsBile acid binding protein
Therapy Area/IndicationsHyperphosphatemiaHypercholesterolemiaDyslipidemias +[5] 
Global Approved IndicationsHyperphosphatemiaHypercholesterolemia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1999/07/01
Country/TerritoryCzechiaCanadaUnited States +[22] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPending
Originator CompaniesMitsubishi Tanabe Pharma
China Registration ClassN/A

Develop Information

Active CompaniesFuji Pharma Co LtdMitsubishi Tanabe Pharma
Inactive CompaniesMitsubishi Tanabe Pharma CorpMitsubishi Tanabe Pharma Europe LtdChengdu Giantech Hi-Technology Development Co Ltd
Active IndicationsHypercholesterolemia
Inactive IndicationsHyperphosphatemiaDyslipidemiasDiabetes Mellitus, Type 2 +[4] 

Other Information

ATC CodeV03AE06
Related LinksKEGG